In today’s ever-evolving healthcare landscape, the importance of diversity and inclusion in clinical trials cannot be overstated. This intriguing panel discussion brought together leading voices from different facets of the industry to address pressing issues around health equity throughout the lifecycle. Joined by Jewel Johnson, Executive Immunology Clinical Account Lead of UCB, moderator Derrick Lane of BlackDoctor.org led a conversation that delved into the experiences and insights shared by panelists Zoma Foster of UCB, Perla Nunez, Clinical Research DEI Thought Leader, and Kendal Whitlock of Walgreens.
This dynamic exchange not only sheds light on strategies for increasing diversity in clinical trials but also reinforces the notion that healthcare solutions demand collective commitment. The discussion advocates moving beyond checking diversity boxes toward fostering enduring partnerships that truly celebrate inclusivity and equity for all.
